{"data":{"id":"us-ca/hsc-439.905","jurisdiction":"us-ca","citation":"HSC § 439.905","heading":"","body":"It is the intent of the Legislature to encourage research on the effectiveness of RU-486 (mifepristone) in treating breast and ovarian cancer, meningioma, endometriosis, Cushing’s syndrome, osteoporosis, diabetes, and AIDS.","path":["Health and Safety Code - HSC","DIVISION 1. ADMINISTRATION OF PUBLIC HEALTH [135. - 1179.102.]","PART 1.6. HEALTH RESEARCH FAIRNESS [439.900. - 439.906.]"],"source_url":"https://downloads.leginfo.legislature.ca.gov/pubinfo_2025.zip","current_through":"2026-09-13","vintage":"","retrieved_at":"2026-09-14T05:56:33Z","sha256":"ceefd5a034fabd5be6fdcf60589363588425593d7d0de6e370584def52fbce01","source_id":"us-ca","stale":false,"prev":"us-ca/hsc-439.904","next":"us-ca/hsc-439.906"},"notice":"GroundRules: Original legal text. Not legal advice."}